Calcium folinate pentahydrate
Liver Metastasis Colon Cancer
Jun HuangSmall moleculePhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 55/ 100
- Competitive Position
- 89/ 100
Competitive context
13 Active assets in the Liver Metastasis Colon Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Eloxatin Fudan University | Phase 4 | BBB |
FLUOROURACILUM Jun Huang | Phase 3 | BB |
Capecitabine Jun Huang | Phase 3 | BB |
Irinotecan Jun Huang | Phase 3 | BB |
Regorafenib First Affiliated Hospital, Sun Yat-Sen University | Phase 2 | B |
View all 15 →
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →